Acción 300534 GANSU LONGSHENRONGFA PHARMACEUTICAL INDUSTRY CO.,LTD
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Acciones

300534

CNE100002CP5

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 21/06/2024 		Varia. Cinco días. Varia. 1 de enero.
7,3 CNY +0,41 % Gráfico intradía de Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD +0,69 % -26,04 %
17/05 Longshenrongfa Pharmaceutical nombra vicepresidente y subdirector general MT
26/04 Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD informa de los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend for 2023, Payable on 06 June 2024
Longshenrongfa Pharmaceutical Appoints Vice Chairman, Deputy General Manager
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Proposes Final Cash Dividend for 2023
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction announced on July 17, 2023
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
Longshenrongfa Pharmaceutical Renews Food Production License
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD announced that it expects to receive CNY 485.796067 million in funding from Gansu Pharmaceutical Investment Group Co., Ltd., Gansu Great Wall Xinglong Silk Road Fund Management Co., Ltd. and other investors.
An unknown buyer agreed to acquire 7.1% stake in Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD for CNY 234.5 million.
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022
Chinese Shares Rebound; Longshenrongfa Pharma Rises 3.9% on Renewal of Drug Production License
Gansu Longshenrongfa Pharma Renews Drug Production License
Drug Regulator Approves Changes to Longshenrongfa Pharma's Drug Production License
Longshenrongfa Pharma Gets Nod for Proposed Changes in License
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd completed the acquisition of 70% stake in Gansu Pu'an Pharmaceutical Co.,Ltd. from Gansu Province Farms Agribusiness Ref co Group Ltd.
Longshenrongfa Pharma Gets Provincial Regulator's Nod for Cough Capsules
Gansu Longshenrongfa Leases Properties to Affiliates
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300534
  4. Noticias Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
  5. Otros idiomas